170832 ⎘
Detection or diagnosis of diseases; Haematology Platelet disorders
COMPOSITIONS AND METHODS FOR ASSAYING PLATELET REACTIVITY AND TREATMENT SELECTION
#2Atomic Description of Immune Complex that Causes Heparin-Induced Thrombocytopenia
#3METHOD FOR ANALYZING DEPENDENT HEPARIN PLATELET ACTIVATION
#4METHODS FOR SELECTING A CANCER PATIENT FOR TREATMENT
#5PRODUCTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA
#6Atomic description of immune complex that causes heparin-induced thrombocytopenia
#7FFN FLUORESCENCE RELEASE ASSAY (FFRA) AND METHODS OF USING SAME
#8METHOD FOR DIAGNOSING A PREDISPOSITION OF A LIVING BEING TO DEVELOP THROMBOCYTOPENIA
#9Compositions and methods for assaying platelet reactivity and treatment selection
#10ANTIBODIES THAT SPECIFICALLY BIND PEPTIDES ASSOCIATED WITH THE PRIMARY IMMUNODEFICIENCIES: WISKOTT-ALDRICH SYNDROME AND X-LINKED AGAMMAGLOBULINEMIA
#11RAPID AND FACILE ANTIBODY DETECTION USING COVALENTLY IMMOBILIZED SELF-ASSEMBLED POLYPEPTIDES
#12Atomic description of immune complex that causes heparin-induced thrombocytopenia
#13SYSTEM AND METHOD FOR A BIOMIMETIC FLUID PROCESSING
#14METHODS AND COMPOSITIONS FOR MONITORING AND DIAGNOSING HEALTHY AND DISEASE STATES
#15IMMUNITY MECHANISM AND THERAPEUTIC DRUG FOR GASTROINTESTINAL DISEASES
#16THE DOUBLE DEAMIDATED FORM OF BCL-XL IS A BIOMARKER OF PLATELET AGE
#17Method for discharging a patient from an intensive care unit
#18METHOD FOR PREPARING A SAMPLE
#19GDF-15 AS A HAEMATOLOGICAL TOXICITY BIOMARKER
#20GDF-15 AS A HAEMATOLOGICAL TOXICITY BIOMARKER
#21Method for analyzing the platelets of a blood sample
#22METHODS FOR THE PREDICTION OF A PERSONALIZED ESA-DOSE IN THE TREATMENT OF ANEMIA
#23Methods and systems for measuring serotonin in a sample
#24A RAPID, ON-DEMAND HEPARIN-INDUCED THROMBOCYTOPENIA FUNCTIONAL ASSAY
#25System and method for a biomimetic fluid processing
#26Proadrenomedullin as a marker for abnormal platelet levels
#27Compositions and methods for assaying platelet reactivity and treatment selection
#28Atomic description of immune complex that causes heparin-induced thrombocytopenia
#29System and method for biomimetic fluid processing
#30Methods and systems for measuring serotonin in a sample
#31Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor
#32Binding assay for the diagnosis of a heparin-induced thrombocytopenia
#33Activation assay for the diagnosis of a heparin-induced thrombocytopenia
#34PLATELET ANALYSIS SYSTEM
#35ANTI-PLATELET RESPONSE AND REACTIVITY TEST USING SYNTHETIC COLLAGEN
#36GDF-15 as a haematological toxicity biomarker
#37Methods and kits for determining von willebrand factor activity in the absence of ristocetin
#38KITS FOR INDENTIFYING AND TREATING SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID
#39Method of detecting platelet activating antibodies that cause heparin-induced thrombocytopenia/thrombosis
#40Atomic description of immune complex that causes heparin-induced thrombocytopenia
#41System and method for a biomimetic fluid processing
#42Methods for the prediction of a personalized ESA-dose in the treatment of anemia
#43Methods and systems for measuring serotonin in a sample
#44Extracellular mitochondrial components for detecting inflammatory reactions and conditions
#45Method of detection of platelet-activating antibodies that cause heparin-induced thrombocytopenia/thrombosis
#46Methods and kits for determining von Willebrand factor activity in the absence of ristocetin
#47COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE
#48System and method for a biomimetic fluid processing
#49Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
#50Collagen-derived recombinant proteins with von Willebrand factor-binding activity
#51Blood analyzer
#52Methods for detecting heparin/platelet factor 4 antibodies
#53ANKRD26 AS A MARKER FOR DIAGNOSIS OF THROMBOCYTOPENIAS
#54Method of Simultaneous Detection of Heparin-Induced Immunoglobulins Types G, A and M
#55Anti-thrombotic compositions and methods for assaying platelet reactivity and treatment selection
#56METHODS AND KITS FOR DIAGNOSING HEPARIN-INDUCED THROMBOCYTOPENIA
#57METHODS AND SYSTEMS FOR MEASURING WHOLE BLOOD PLATELET REACTIVITY
#58Platelet analysis system
#59Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
#60Moesin fragments associated with immune thrombocytopenia
#61Methods and kits for determining von Willebrand factor activity in the absence of ristocetin and for determining the activity of ADAMTS-13 protease
#62Microchip for platelet examination and platelet examination device using same
#63Method for Determining the Risk of Clopidogrel Resistance
#64USE OF PROTEIN ARGININE METHYLTRANSFERASES IN REGULATING HEMATOPOIETIC DIFFERENTIATION
#65Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
#66COMPOSITIONS AND METHODS FOR PROLONGING SURVIVAL OF PLATELETS
#67Treatment of cardiovascular disease and thrombosis
#68WHOLE BLOOD ASSAY OF AN INTRACELLULAR BIOMARKER OF A CELL SIGNALLING PATHWAY USE IN MEASURING THE ACTIVATION OF A PREDETERMINED CELL POPULATION
#69Integrated Diagnosis of Heparin-Induced Thrombocytopenia
#70Naphthalene-based inhibitors of anti-apoptotic proteins
#71BIOMARKER FOR THE MONITORING AND PROGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS
#72Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
#73Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#74Modified anti-heparin/PF4 complex antibody and HIT antibody standard
#75One step nanosensor for single and multidrug resistance in acute coronary syndrome (ACS)
#76DIAGNOSTIC IN VITRO METHOD FOR ASSESSING VON WILLEBRAND DISEASE AND INCREASED BLEEDING RISK ASSOCIATED WITH VON WILLEBRAND DISEASE AND ACQUIRED OR CONGENITAL DISORDERS OF PLATELET FUNCTION
#77Naphthalene-based inhibitors of anti-apoptotic proteins
#78Rapid and sensitive method for quantitative determination of the level of heparin—PF4 complex induced immunoglobulin antibodies
#79Methods for measuring platelet reactivity of individuals treated with drug eluting stents
#80GPIIIa gene
#81Methods and kits for determining von willebrand factor activity in the absence of ristocetin
#82Method and kit for the detection of heparin-dependent antibodies and the diagnosis of immune or autoimmune pathologies potentiated by heparin, such as heparin-induced thrombocytopenia
#83METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID
#84Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same
#85COMPOSITIONS AND METHODS FOR PROLONGING SURVIVAL OF PLATELETS
#86Methods and Reagents for Elimination or Reduction of False Positives in the Analysis of a Sample
#87Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions
#88Methods and assays for distinguishing between different forms of diseases and disorders characterized by thrombocytopenia and/or by spontaneous interaction between Von Willebrand Factor (vWF) and platelets
#89Method of detecting thrombosis by measuring von Willenbrand factor-cleaving protease
#90Methods for measuring platelet reactivity of patients that have received drug eluting stents
#91Methods of assessing susceptibility to drug-induced thrombocytopenia
#92Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#93RECOMBINANT PLATELET COLLAGEN RECEPTOR GLYCOPROTEIN VI AND ITS PHARMACEUTICAL USE
#94Variants of cytochrome c and methods of diagnosis of thrombocytopenia
#95Platelet biomarkers for the detection of disease
#96Methods and kits for detecting heparin/platelet factor 4 antibodies
#97Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
#98Platelet biomarkers for the detection of disease